The aim of this study is to test the effect of cognitive stimulation (CS), applied individually and at home, on the overall cognitive functioning, emotional state, functionality, and quality of life (QoL) in adults with psychotic disorders. To this end, a randomised controlled clinical trial will be conducted in which selected participants will be randomly assigned to an individual intervention group using CS or a control group. The CS program is adapted from other existing protocol, composed of 32 sessions. Each session will last 45 minutes and will be held twice weekly. There will be four evaluation points (baseline, intra-evaluation - after 8 weeks of intervention, post-evaluation - after 16 weeks of intervention, follow-up - after 8 weeks of the end of intervention).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cognitive functioning evaluated through Montreal Cognitive Assessment [MoCA]
Timeframe: baseline
Change in cognitive functioning evaluated through MoCA
Timeframe: 8 weeks after the beginning of the intervention
Change in cognitive functioning evaluated through MoCA
Timeframe: 16 weeks after the beginning of the intervention
Change in cognitive functioning evaluated through MoCA
Timeframe: 8 weeks after end of intervention
Executive functions evaluated through Frontal Assessment Battery (FAB)
Timeframe: baseline
Change in executive functions evaluated through FAB
Timeframe: 8 weeks after the beginning of the intervention
Change in executive functions evaluated through FAB
Timeframe: 16 weeks after the beginning of the intervention
Change in executive functions evaluated through FAB
Timeframe: 8 weeks after end of intervention